<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.niprovascularinnovations.com/sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<!-- Sitemap is generated on 2026-04-03 15:27:24 GMT -->
	<url>
		<loc>https://www.niprovascularinnovations.com/</loc>
		<lastmod>2026-03-31T20:48:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/sscp/</loc>
		<lastmod>2026-03-29T03:30:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/smartimaging-eula/</loc>
		<lastmod>2026-03-29T03:44:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/intellectual-property/</loc>
		<lastmod>2026-03-29T03:48:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/notice-of-organizational-changes-and-consolidation-of-u-s-subsidiaries-in-vascular-division/</loc>
		<lastmod>2026-03-10T15:48:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-a-nipro-company-announces-enrollment-of-first-patient-in-expanse-ptca-study/</loc>
		<lastmod>2021-12-22T17:48:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/nipro-medical-corporation-nmc/</loc>
		<lastmod>2021-09-08T22:20:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-a-nipro-company-and-nipro-medical-corporation-nmc-a-leading-renal-medical-surgical-and-international-radiology-products-manufacturer-announced-a-collaboration-between-the-two-entiti/</loc>
		<lastmod>2021-04-16T19:44:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-a-nipro-company-and-b-braun-interventional-systems-inc-an-affiliate-of-b-braun-medical-inc-announce-strategic-u-s-collaboration-to-execute-the-ide-clinical-trial-for-the-sequent/</loc>
		<lastmod>2025-03-20T14:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/results-of-the-prospect-ii-natural-history-study-demonstrate-high-risk-plaques-identified-by-nirsivus-imaging-are-linked-to-future-coronary-events/</loc>
		<lastmod>2020-10-14T16:03:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/scanmed/</loc>
		<lastmod>2021-01-25T04:13:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/nipro/</loc>
		<lastmod>2021-01-25T04:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/ji-medical/</loc>
		<lastmod>2021-01-25T04:15:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/infraredx/</loc>
		<lastmod>2021-09-10T15:17:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/focus-medical/</loc>
		<lastmod>2021-03-11T16:05:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/eukon/</loc>
		<lastmod>2021-01-25T04:17:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/product/adyton-medical-devices/</loc>
		<lastmod>2021-01-25T04:18:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/dr-guilio-guagliumi-discusses-the-use-of-ivusnirs-imaging-for-decision-making-in-acute-coronary-syndrome-during-the-2020-europcr-e-course/</loc>
		<lastmod>2020-07-30T15:46:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/covid-19-pandemic-message-from-our-president-ceo/</loc>
		<lastmod>2020-03-30T20:06:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/study-shows-safety-and-efficacy-of-near-infrared-spectroscopy-nirs-imaging-to-identify-patients-and-plaques-at-an-increased-risk-for-mace/</loc>
		<lastmod>2019-09-27T19:08:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-nipro-company-announces-fda-approval-expanded-label-claim-makototm-intravascular-imaging-system/</loc>
		<lastmod>2019-09-18T21:53:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/landmark-lipid-rich-plaque-lrp-study-results-demonstrate-ability-accurately-identify-patients-and-plaques-at-risk-for-major-coronary-events/</loc>
		<lastmod>2019-09-17T16:41:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-to-present-results-of-the-lipid-rich-plaque-lrp-study-at-the-transcatheter-cardiovascular-therapeutics-tct-2018-scientific-symposium/</loc>
		<lastmod>2019-09-17T16:41:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/announces-launch-of-makoto-intravascular-imaging-system-and-dualpro-ivusnirs-catheter-japan/</loc>
		<lastmod>2019-09-17T16:41:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.niprovascularinnovations.com/infraredx-highlights-value-ivus-nirs-detecting-lipid-core-plaque-american-college-scientific-session/</loc>
		<lastmod>2019-09-17T16:42:14+00:00</lastmod>
	</url>
</urlset>
<!-- Sitemap is generated for this view -->
